161 related articles for article (PubMed ID: 12667381)
21. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma.
Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG
Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224
[TBL] [Abstract][Full Text] [Related]
22. Reduction of p12DOC-1 expression is a negative prognostic indicator in patients with surgically resected oral squamous cell carcinoma.
Shintani S; Mihara M; Terakado N; Nakahara Y; Matsumura T; Kohno Y; Ohyama H; McBride J; Kent R; Todd R; Tsuji T; Wong DT
Clin Cancer Res; 2001 Sep; 7(9):2776-82. PubMed ID: 11555592
[TBL] [Abstract][Full Text] [Related]
23. [Detection of cell cycle related gene expression in cultured immortalized human lens epithelial cell].
Wu M; Li S; Zeng J; Gao J; Liu Y
Zhonghua Yan Ke Za Zhi; 2002 Jun; 38(6):367-71. PubMed ID: 12139816
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
[TBL] [Abstract][Full Text] [Related]
25. The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics.
Vlachos P; Joseph B
Oncogene; 2009 Nov; 28(47):4175-88. PubMed ID: 19734939
[TBL] [Abstract][Full Text] [Related]
26. Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas.
Dobashi Y; Jiang SX; Shoji M; Morinaga S; Kameya T
J Pathol; 2003 Feb; 199(2):208-20. PubMed ID: 12533834
[TBL] [Abstract][Full Text] [Related]
27. Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes.
Curry JL; Richards HW; Huttenbach YT; Medrano EE; Reed JA
J Cutan Pathol; 2009 Feb; 36(2):197-205. PubMed ID: 18647205
[TBL] [Abstract][Full Text] [Related]
28. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.
Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F
Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832
[TBL] [Abstract][Full Text] [Related]
29. Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival.
Rosenberg E; Demopoulos RI; Zeleniuch-Jacquotte A; Yee H; Sorich J; Speyer JL; Newcomb EW
Hum Pathol; 2001 Aug; 32(8):808-13. PubMed ID: 11521224
[TBL] [Abstract][Full Text] [Related]
30. Expression of cell cycle regulator p57kip2, cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: an immunohistochemical study.
Yue H; Jiang HY
World J Gastroenterol; 2005 Aug; 11(32):5057-60. PubMed ID: 16124066
[TBL] [Abstract][Full Text] [Related]
31. [p57KIP2 in muscle differentiation, simpler than CKI].
Tintignac L; Leibovitch MP; Leibovitch SA
Bull Cancer; 2000 Jul; 87(7-8):521. PubMed ID: 10969203
[No Abstract] [Full Text] [Related]
32. Decreased expression of decorin and p57(KIP2) correlates with poor survival and lymphatic metastasis in lung cancer patients.
Biaoxue R; Xiguang C; Hua L; Hui M; Shuanying Y; Wei Z; Wenli S; Jie D
Int J Biol Markers; 2011; 26(1):9-21. PubMed ID: 21360479
[TBL] [Abstract][Full Text] [Related]
33. Cyclin E overexpression responsible for growth of human hepatic tumors with p21WAF1/CIP1/SDI1.
Tsuji T; Miyazaki M; Fushimi K; Mihara K; Inoue Y; Ohashi R; Ohtsubo M; Hamazaki K; Furusako S; Namba M
Biochem Biophys Res Commun; 1998 Jan; 242(2):317-21. PubMed ID: 9446792
[TBL] [Abstract][Full Text] [Related]
34. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.
Yan Y; Frisén J; Lee MH; Massagué J; Barbacid M
Genes Dev; 1997 Apr; 11(8):973-83. PubMed ID: 9136926
[TBL] [Abstract][Full Text] [Related]
35. Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle.
Hattori N; Davies TC; Anson-Cartwright L; Cross JC
Mol Biol Cell; 2000 Mar; 11(3):1037-45. PubMed ID: 10712518
[TBL] [Abstract][Full Text] [Related]
36. E1A modulates phosphorylation of p130 and p107 by differentially regulating the activity of G1/S cyclin/CDK complexes.
Parreño M; Garriga J; Limón A; Albrecht JH; Graña X
Oncogene; 2001 Aug; 20(35):4793-806. PubMed ID: 11521191
[TBL] [Abstract][Full Text] [Related]
37. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes.
Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E
Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654
[TBL] [Abstract][Full Text] [Related]
38. The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway.
Vlachos P; Nyman U; Hajji N; Joseph B
Cell Death Differ; 2007 Aug; 14(8):1497-507. PubMed ID: 17464323
[TBL] [Abstract][Full Text] [Related]
39. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer.
Liang B; Wang S; Zhu XG; Yu YX; Cui ZR; Yu YZ
World J Gastroenterol; 2005 Feb; 11(5):623-8. PubMed ID: 15655810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
